Chronic Myeloproliferative Disorders Completed Phase 1 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003331Combination Chemotherapy in Treating Patients With Advanced CancerTreatment